SEARCH

SEARCH BY CITATION

References

  • De Maat, M.P., Bladbjerg, E.M., Johansen, L.G., Bentzen, J., Jespersen, J. (1997) PlA1/A2 polymorphism of platelet glycoprotein IIIa and risk of cardiovascular disease [letter]. Lancet, 349, 1099 1100.
  • Dominguez-Jimenez, C., Diaz-Gonzalez, F., Gonzalez-Alvaro, I., Cesar, J.M., Sanchez-Madrid, F. (1999) Prevention of αIIbβ3 activation by non-steroidal antiinflammatory drugs. FEBS Letters, 446, 318 322.DOI: 10.1016/s0014-5793(99)00236-7
  • Feng, D., Lindpaintner, K., Larson, M.C., Rao, V.S., O'donnell, C.J., Lipinska, I., Schmitz, C., Sutherland, P.A., Silbershatz, H., D'agostino, R.B., Muller, J.E., Myers, R.H., Levy, D., Tofler, G.H. (1999) Increased platelet aggregability associated with platelet GPIIIa PlA2 polymorphism: the Framingham Offspring Study. Arteriosclerosis, Thrombosis and Vascular Biology, 19, 1142 1147.
  • Fiore, L.D., Brophy, M.T., Lopez, A., Janson, P., Deykin, D. (1990) The bleeding time response to aspirin. Identifying the hyperresponder. American Journal of Clinical Pathology, 94, 292 296.
  • Goodall, A.H., Curzon, N., Panesar, M., Hurd, C., Knight, C.J., Ouwehand, W.H., Fox, K.M. (1999) Increased binding of fibrinogen to glycoprotein IIIa proline 33 (HPA-1b, PlA2, Zwb) positive platelets in patients with cardiovascular disease. European Heart Journal, 20, 742 747.DOI: 10.1053/euhj.1998.1203
  • Grotemeyer, K.H., Scharafinski, H.W., Husstedt, I.W. (1993) Two-year follow-up of aspirin responder and aspirin non-responder. A pilot study including 180 post-stroke patients. Thrombosis Research, 71, 397 403.
  • Kauhanen, P., Kovanen, P.T., Reunala, T., Lassila, R. (1998) Effects of skin mast cells on bleeding time and coagulation activation at the site of platelet plug formation. Thrombosis and Haemostasis, 79, 843 847.
  • Kottke-Marchant, K., Poggio, E.D., Welsh, P.A., Brooks, L.M., Topol, E.J. (1999) Functional aspirin resistance in cardiac patients: Platelet aggregation compared to PFA-100. Thrombosis and Haemostasis , 82, (Suppl.), abstract 1251.
  • Peter, K., Schwarz, M., Ylänne, J., Kohler, B., Moser, M., Nordt, T., Salbach, P., Kübler, W., Bode, CH. (1998) Induction of fibrinogen binding and platelet aggregation as a potential intrinsic property of various glycoprotein IIb/IIIa (αIIbβ3) inhibitors. Blood, 92, 3240 3249.
  • Szczeklik, A., Milne, P.C., Birch, J., Watkins, J., Martin, J.F. (1986) Prolonged bleeding time, reduced aggregation, altered PAF-acether sensitivity and increased platelet mass are a trait of asthma and hay fever. Thrombosis and Haemostasis, 56, 283 287.
  • Szczeklik, A., Musial, J., Undas, A., Swadzba, J., Gora, P., Piwowarska, W., Duplaga, M. (1996) Inhibition of thrombin generation by aspirin is blunted in hypercholesterolemia. Arteriosclerosis, Thrombosis and Vascular Biology, 96, 258 262.
  • Undas, A., Sanak, M., Musial, J., Szczeklik, A. (1999) Platelet glycoprotein IIIa polymorphism, aspirin, and thrombin generation. Lancet, 353, 982 983.DOI: 10.1016/s0140-6736(98)05054-5